Physician Assistant, Medical · Boston, MA
NPI
1730548595
Since 2016
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
450 Brookline Ave
Boston, MA, 02215
Phone (617) 632-3000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.4M
679 prescriptions
Company payments, 2025
$79.42
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Alexandra E Lynch prescribed most often to Medicare patients was Acyclovir, with 77 prescriptions and refills. In total Alexandra E Lynch wrote 679 Medicare prescriptions that cost $1.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Acyclovir Generic | 77 | 151 | 42 | $1,196 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 63 | 127 | 30 | $495 |
| Prednisone Generic | 39 | 41 | 25 | $74.23 |
| Brukinsa Zanubrutinib | 35 | 35 | Under 11 | $371K |
| Lorazepam Generic | 23 | 24 | 12 | $79.16 |
| Cotellic Cobimetinib Fumarate | 22 | 22 | Under 11 | $60K |
| Gabapentin Generic | 21 | 22 | Under 11 | $305 |
| Loperamide Loperamide Hcl | 18 | 18 | Under 11 | $518 |
| Imbruvica Ibrutinib | 18 | 18 | Under 11 | $300K |
| Ondansetron Hcl Generic | 17 | 17 | 13 | $172 |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $74.84 |
| Revlimid Lenalidomide | 15 | 15 | Under 11 | $264K |
| Atovaquone Generic | 15 | 15 | Under 11 | $4,991 |
| Allopurinol Generic | 15 | 17 | 14 | $50.2 |
| Valacyclovir Valacyclovir Hcl | 12 | 24 | Under 11 | $850 |
Brand drugs: - claims; generic drugs: 529 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexandra E Lynch $79.42 ($79.42 in general payments such as food, travel and fees) from 1 company. The largest payer was Genmab U.S., Inc. with $79.42.
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. GMAB | 1 | $79.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.